Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhongchao (ZCMD) Cash & Equivalents (2018 - 2025)

Zhongchao has reported Cash & Equivalents over the past 8 years, most recently at $8.1 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 3.27% to $8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Dec 2025, up 3.27% year-over-year, with the annual reading at $8.1 million for FY2025, 3.27% up from the prior year.
  • Cash & Equivalents was $8.1 million for Q4 2025 at Zhongchao, down from $8.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $13.9 million in Q4 2021 and troughed at $6.3 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $11.4 million (2022), against an average of $10.6 million.
  • Year-over-year, Cash & Equivalents surged 94.48% in 2021 and then crashed 44.36% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $13.9 million in 2021, then decreased by 17.21% to $11.5 million in 2022, then rose by 18.16% to $13.6 million in 2023, then crashed by 42.4% to $7.8 million in 2024, then grew by 3.27% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for ZCMD's Cash & Equivalents are $8.1 million (Q4 2025), $8.9 million (Q2 2025), and $7.8 million (Q4 2024).